Rapid Response 2026: Biomarkers program

The Weston Family Foundation aims to catalyze and scale science-based approaches to significantly improve the health and well-being of Canadians. The Foundation takes a leadership role in tackling large problems that are under-addressed by supporting research that is particularly relevant to the health of Canadians and that empowers Canadians to improve their health and wellbeing. 

The Foundation, through the Weston Brain Institute, is pleased to announce the re-launch of the Rapid Response program with a focus on biomarkers. The Rapid Response 2026: Biomarkers program provides early-stage seed funding to support high-risk, high-reward translational research aimed at accelerating the validation to clinical implementation of biomarkers for neurodegenerative diseases of aging (NDAs).